The Division of Pulmonary and Critical Care Medicine comprises of 29 full-time faculty members who have an extensive range of clinical and research interests. This allows us to offer ample opportunities for one-on-one faculty-fellow mentorship while also delivering breadth and depth of expertise. Our aim is to provide exceptional care to our patients as well as outstanding clinical and research training to our fellows.
Our division treats patients with a range of pulmonary and respiratory ailments, including obstructive airway diseases such as asthma and COPD, restrictive lung diseases such as idiopathic pulmonary fibrosis and occupationally acquired lung disease, sleep-related breathing disorders such as obstructive sleep apnea, and acute lung injury in the critical care setting. Our interventional colleagues work closely with Oncology to diagnose and treat lung cancer patients. The Transplant Pulmonary group evaluates patients who are being considered for lung transplant and cares for post-operative transplant patients.
Keynote Address: "Measuring What Matters: An Overview of Patient Centered Outcomes in Interstitial Lung Disease" - Kerri Aronson, MS, MD, Assistant Professor of Medicine, Weill Cornell Medical College
When: Nov 1st, 2025, 8:00am - 2:00pm
Where: Educational Resource Center, 1240 Lee Street, Charlottesville, Virginia
Deadlines: In-person Registration: October 27th, 2025
The Pulmonary and Critical Care Fellowship at UVA is a three-year program that provides a strong background in clinical pulmonary medicine and the management of critically ill patients. At least 12 months of research experience is provided in the clinical research track. A second 18-month research experience is offered for fellows interested in the academic research track. Research may be in either clinical or basic science.
We are an ACGME-accredited clinical Sleep Medicine Fellowship program that spans 12 months. The overarching goal of the UVA Sleep Medicine Fellowship is to provide a supportive learning environment for our fellows to become comprehensive experts in sleep medicine. Upon completing the fellowship program, our fellows will be board-eligible in Sleep Medicine.
UVA Health researchers are uncovering blood-based indicators that could help predict the onset of lung disease.
Researchers at UVA Health are hoping that their latest efforts will lead to an approach to detecting patients at risk of interstitial lung disease, an increasingly common condition that is a leading reason for lung transplants. Led by Dr. John Kim, they believe that certain biological indicators in the blood — already useful in predicting the survival of ILD patients — can also be used to predict whether people will develop the disease at all.
Dr. Kyle Enfield breaks down the symptoms, challenges and misunderstandings of long COVID
Kyle Enfield, an Internal Medicine doctor and professor of medicine, said the term ‘long COVID’ was defined by patients early in the course of pandemic. He said patients have have struggled with post-viral symptoms with other viral illnesses, and likely not just COVID. “There were patients who had COVID, had felt like they should have recovered but continued to have issues with fatigue specifically,” Enfield said. “That term long COVID is really one that came from the patient community and was adopted by the medical community.“
Imre Noth, MD, Research In Motion
Imre Noth, MD, Professor in the Department of Medicine, investigates interstitial lung diseases using translational biology and clinical trials to develop and monitor new treatments. "I work in a rare and uncommon set of diseases called interstitial lung diseases. These can be deadly with a high mortality, and I’ve had the benefit of living through two approved therapies, with more coming, from an era that had none." —Imre Noth, MD, Professor of the Department of Medicine, Chief of the Division of Pulmonary and Critical Care Medicine
Division of Hospital Medicine Research and Educational Updates – November 2025
Message from Division Chief, Amber Inofuentes MD, Division of Hospital Medicine Hospital Medicine’s inaugural year as a Division was marked by significant growth, innovation, and excellence in both clinical care…Division of Nephrology Research and Educational Updates – September 2025
Message from Dr. Mark Okusa, Division Chief of Nephrology Recent changes emanating from Washington, D.C., have introduced new challenges to our academic mission, including cuts in federal research funding and…